Steroids Provide Temporary Improvement of Refractory Pain Following Subarachnoid Hemorrhage
- 28 April 2023
- journal article
- research article
- Published by SAGE Publications in The Neurohospitalist
- Vol. 13 (3) , 236-242
Abstract
Introduction: Evidence for optimal analgesia following subarachnoid hemorrhage (SAH) is limited. Steroid therapy for pain refractory to standard regimens is common despite lack of evidence for its efficacy. We sought to determine if steroids reduced pain or utilization of other analgesics when given for refractory headache following SAH. Methods: We performed a retrospective within-subjects cohort study of SAH patients who received steroids for refractory headache. We compared daily pain scores, total daily opioid, and acetaminophen doses before, during, and after steroids. Repeated measures were analyzed with a multivariable general linear model and generalized estimating equations. Results: Included 52 patients treated with dexamethasone following SAH, of whom 11 received a second course, increasing total to 63 treatment epochs. Mean pain score on the first day of therapy was 7.92 (standard error of the mean [SEM] .37) and decreased to 6.68 (SEM .36) on the second day before quickly returning to baseline levels, 7.36 (SEM .33), following completion of treatment. Total daily analgesics mirrored this trend. Mean total opioid and acetaminophen doses on days one and two and two days after treatment were 47.83mg (SEM 6.22) and 1848mg (SEM 170.66), 34.24mg (SEM 5.12) and 1809mg (SEM 150.28), and 46.38mg (SEM 11.64) and 1833mg (SEM 174.23), respectively. Response to therapy was associated with older age, decreasing acetaminophen dosing, and longer duration of steroids. Hyperglycemia and sleep disturbance/delirium effected 28.6% and 55.6% of cases, respectively. Conclusion: Steroid therapy for refractory pain in SAH patients may have modest, transient effects in select patients.Keywords
Funding Information
- University of Maryland Baltimore, Institute for Clinical and Translational Research (Grant #1UL1TR003098)
- Department of Veterans Affairs ((I01BX002889, I01BX004652))
- the National Heart, Lung and Blood Institute ((R01HL082517))
- the National Institute of Neurological Disorders and Stroke (R01NS102589, R01NS105633)
This publication has 29 references indexed in Scilit:
- The Course of Headache in Patients With Moderate‐to‐Severe Headache Due to Aneurysmal Subarachnoid Hemorrhage: A Retrospective Cross‐Sectional StudyHeadache: The Journal of Head and Face Pain, 2015
- Safety and Tolerability of Gabapentin for Aneurysmal Subarachnoid Hemorrhage (SAH) Headache and MeningismusNeurocritical Care, 2014
- BET 2: Dexamethasone for reduction of migraine recurrenceEmergency Medicine Journal, 2013
- Corticosteroids for acute ischaemic strokeCochrane Database of Systematic Reviews, 2011
- Magnesium and headache after aneurysmal subarachnoid haemorrhageJournal of Neurology, Neurosurgery & Psychiatry, 2009
- Patient-perceived satisfactory improvement (PPSI): Interpreting meaningful change in pain from the patient’s perspectivePain, 2006
- Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhageCochrane Database of Systematic Reviews, 2005
- Effect of intravenous corticosteroids on death within 14 days in 10 008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trialThe Lancet, 2004
- Clinically Important Changes in Acute Pain Outcome MeasuresJournal of Pain and Symptom Management, 2003
- What is the maximum number of levels needed in pain intensity measurement?Pain, 1994